Comfort and Tolerance of Surface Neuro Muscular Electrical Stimulation in Parkinson's Disease.
An Evaluation of Comfort and Tolerance of Surface Neuro Muscular Electrical Stimulation (NMES), When Applied to Parkinson's Disease Patients for Both Sensory and Motor Activation.
1 other identifier
interventional
10
1 country
1
Brief Summary
The purpose of this study is to investigate issues relating to comfort and tolerance to surface neuro muscular electrical stimulation in a parkinson disease population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2013
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
September 9, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2013
CompletedFirst Posted
Study publicly available on registry
October 24, 2013
CompletedOctober 24, 2013
October 1, 2013
1 month
September 9, 2013
October 19, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient comfort in response to neuromuscular electrical stimulation in Parkinson's disease.
Participants will be tested over a range of stimulation intensities at different muscle sites. Primary outcome measure will be patient comfort and tolerance to neuromuscular electrical stimulation.
1 day
Study Arms (1)
NMES Device comfort
EXPERIMENTALNMES Device comfort, establishing Sensory, Motor and Pain thresholds. Max Pain tolerance is also established.
Interventions
NMES device, establishing Sensory, Motor and Pain thresholds and Pain tolerance.
Eligibility Criteria
You may qualify if:
- A diagnosis of idiopathic PD (UK, PD Brain Bank Criteria)
- A Hoehn and Yahr stage of 2 - 4
- Exhibiting Freezing of Gait or another gait abnormalityin the ON or OFF state.
- An ability to mobilise independently for the purpose of research when in the 'off' state
- An ability to walk unaided for 10 meters.
You may not qualify if:
- A serious cognitive impairment (MMSE\<24)
- Pregnant or currently involved in another clinical trial.
- Uncontrolled heart problems
- Pacemakers
- On opioid or neuropathic pain medication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Galway
Galway, Ireland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gearoid O'Laighin, PhD
Electrical & Electronic Engineering NUI Galway
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 9, 2013
First Posted
October 24, 2013
Study Start
September 1, 2013
Primary Completion
October 1, 2013
Study Completion
October 1, 2013
Last Updated
October 24, 2013
Record last verified: 2013-10